Comparing Fasenra vs Trelegy Ellipta
| Fasenra (benralizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|---|
| Fasenra (benralizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
[Fasenra](https://www.drugs.com/fasenra.html) is a biologic that may be used to treat severe eosinophilic asthma in adults and children aged 6 years and older or eosinophilic granulomatosis with... View more |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions Popular comparisons
|
|||||||
| More about Fasenra (benralizumab) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||
| Ratings & Reviews | |||||||||
|
Fasenra has an average rating of 7.8 out of 10 from a total of 76 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.9 out of 10 from a total of 256 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||
| Drug Class | |||||||||
| Side Effects | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Trelegy Ellipta prices |
||||||||
| Dosage Forms Available | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
|
360 hours |
24 hours |
||||||||
| CSA Schedule ** View glossary of terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 20 drugs are known to interact with Fasenra:
|
A total of 536 drugs are known to interact with Trelegy Ellipta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 14, 2017 |
September 18, 2017 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.